Key facts
- Vitrolife Group appointed Olivier Desmarets as Chief Operations Officer.
- The appointment is effective June 1, 2026.
- Desmarets succeeds Ermanno Sironi, who is retiring.
- Desmarets will lead the company's operations.
Vitrolife Group is a global medical device company specializing in reproductive health. The company's products and services support fertility treatments and diagnostics. This leadership change is part of the company's ongoing succession planning.